Your browser doesn't support javascript.
loading
Pain relief during intrauterine device placement in nulligravid women with both oral ketorolac and an analgesic: a double-blinded randomised trial.
Marcelino, Ana C; da Cunha Pereira, Paula; Charles, Charles M; Espejo-Arce, Ximena; Bahamondes, Luis.
Afiliação
  • Marcelino AC; Department of Obstetrics and Gynaecology, Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
  • da Cunha Pereira P; Department of Obstetrics and Gynaecology, Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
  • Charles CM; Department of Obstetrics and Gynaecology, Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
  • Espejo-Arce X; Department of Obstetrics and Gynaecology, Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
  • Bahamondes L; Department of Obstetrics and Gynaecology, Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
Article em En | MEDLINE | ID: mdl-39279687
ABSTRACT

OBJECTIVE:

We assessed whether the administration of oral ketorolac with an analgesic provides effective pain relief during placement of an intrauterine device (IUD) in nulligravid women.

METHODS:

We conducted a double-blinded randomised trial in the Department of Obstetrics and Gynaecology, University of Campinas Faculty of Medical Sciences, Campinas, SP, Brazil. We randomised participants who voluntarily agreed to participate to receive either one pill containing ketorolac 20 mg together with one pill containing dipyrone 300 mg, scopolamine 6.5 µg, hyoscyamine 104 µg, and homatropine 1 mg or placebo 60 min before IUD placement. The participants and providers were blinded to the randomisation group. The primary outcome was pain assessment (measured on a 0-10 visual analogue scale) during IUD placement.

RESULTS:

We enrolled participants and randomised them 11 between November 7, 2023, and January 31, 2024. We analysed 60 women in each group. There were no differences between the groups in the pain score during tenaculum placement, uterine sounding, and IUD placement, and in the overall perception of pain. However, the pain score was significantly lower 10 min after the procedure in women who received the treatment compared with women who received the placebo.

CONCLUSION:

Oral ketorolac associated with an analgesic administered 60 min before IUD placement was not significantly better than placebo during tenaculum placement, uterine sounding, and IUD insertion, and did not significantly reduce the overall pain perception. However, this treatment did significantly reduce pain 10 min after the procedure. TRIAL REGISTRATION The trial was registered at Registro Brasileiro de Ensaios Clínicos (REBEC; in English The Brazilian Registry of Clinical Trials) under number RBR-7phn8yv on November 6, 2023. https//ensaiosclinicos.gov.br/rg/RBR-7phn8yv.
Pain at IUD placement after one pill containing ketorolac 20 mg together with one analgesic pill given 60 min before placement were similar than placebo.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Contracept Reprod Health Care Assunto da revista: MEDICINA REPRODUTIVA / SERVICOS DE PLANEJAMENTO FAMILIAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Contracept Reprod Health Care Assunto da revista: MEDICINA REPRODUTIVA / SERVICOS DE PLANEJAMENTO FAMILIAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido